Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut is a research paper published in Cell Host & Microbe (2023). On theSindex it has a DataRank of 0. It has been cited 131 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: AI064285
NIH
Grant: DK113599
Crohn's and Colitis Foundation
Grant: 654758
IFM Therapeutics
Grant: 9,951,340
NIAID NIH HHS
Grant: R01 AI128360
NIDDK NIH HHS
Grant: R01 DK113599
NIAID NIH HHS
Grant: R56 AI064285
NIAID NIH HHS
Grant: R01 AI064285
Crohn's and Colitis Foundation
Dana-Farber Cancer Institute
Massachusetts General Hospital
Kenneth Rainin Foundation
Australian Government Department of Education
MeSH Terms
Keywords
Additional file 1 of Secretion of functional interferon by the type 3 secretion system of enteropathogenic Escherichia coli
Additional file 1 of Secretion of functional interferon by the type 3 secretion system of enteropathogenic Escherichia coli
Additional file 2 of Secretion of functional interferon by the type 3 secretion system of enteropathogenic Escherichia coli
Additional file 2 of Secretion of functional interferon by the type 3 secretion system of enteropathogenic Escherichia coli